Want to join the conversation?
Pharma company $NVS reported positive results of Phase III EXPAND study. It showed that oral once-daily BAF312 (siponimod) significantly reduced risk of disability progression versus placebo in people with secondary progressive multiple sclerosis. This is a form of multiple sclerosis with continuous worsening of neurological function over time.
$PYPL jumps 6% in after hours on strong results. I am bullish on this stock.
$TSCO stock remained active in the after hours trading and rose more than 2% after the retailer posted better than expected 1Q17 results.
Instagram has reached 700 million monthly active users. Looks like it will hit 1 billion soon. That would make it $FB’s fourth billion-user platform.